Advertising

The Seattle Times Company

NWjobs | NWautos | NWhomes | NWsource | Free Classifieds | seattletimes.com

The Seattle Times

Biotech


Our network sites seattletimes.com | Advanced

Originally published Tuesday, January 8, 2008 at 12:00 AM

E-mail article     Print view

Seattle Genetics gets shot of cash

Seattle Genetics said Monday it had received a $4 million milestone payment from partner Genentech to begin an early clinical trial on its...

Seattle Times business reporter

SAN FRANCISCO Seattle Genetics said Monday it had received a $4 million milestone payment from partner Genentech to begin an early clinical trial on its lead blood-cancer drug.

The Bothell company now has received between $80 million and $90 million from the San Francisco biotech giant, including $20 million in milestone payments, said Seattle Genetics Chief Executive Clay Siegall.

The deal, which gives Genentech the U.S. and international rights to commercialize the therapy known as SGN-40, was signed in 2007.

"Genentech committed to paying $20 million in milestones in over two years. We've already done that" in one year, Siegall said on the sidelines of the JP Morgan biotech conference in San Francisco.

The cash influx from Genentech last year gave the Seattle area's second-largest biotech company ample cash to finance its operations.

This year, Seattle Genetics plans to ramp up clinical programs for two other experimental therapies that have had promising results.

The company has 200 employees and plans to hire 50 more this year, Siegall said.

While similar arrangements with big partners could represent a great deal of money, Seattle Genetics may opt for a larger degree of independence in its follow-up products.

"We're excited to consider an international deal but we'd like to keep the U.S. [rights]," Siegall said.

Seattle Genetics shares closed Monday at $11.14, up 7.32 percent.

Ángel González: 206-515-5644 or agonzalez@seattletimes.com

Copyright © 2008 The Seattle Times Company

More Biotech headlines...

E-mail article Print view      Share:    Digg     Newsvine

advertising

UPDATE - 01:37 PM
Cell Therapeutics stock resumes trading after week-long halt

Advertising

Video

Real Salt Lake wins MLS Cup
Real Salt Lake defeated the Los Angeles Galaxy with penalty kicks after 120 minutes of play at Qwest Field in Seattle.

Raw Video | Real Salt Lake receives the MLS Cup trophy
Raw Video | Real Salt Lake fans celebrate
Real Salt Lake fans enter Qwest Field
Raw Video | MLS Cup Opening Ceremony
LA Galaxy's David Beckham
Real Salt Lake's Kyle Beckerman
MLS trophy arrives in Seattle
Chittenden Locks Inspection
Full interview with New Moon actors

Marketplace

Open Houses

Find this weekend's open house listings.
Or search by location:

nwautos

Less is more: Group rides, good gas mileage have led to a scooter swarm in Seattlenew
Local riders say they've seen a surge in scooter interest in recent years, mostly from people wanting another commuting option. Seattle now ranks as o...
Post a comment

Advertising